Skip to content
Sign in
CVE-2022-24040Not scoredCWE-400

CVE-2022-24040: Siemens Desigo DXR2 vulnerability

Siemens · Desigo DXR2

Affected: Siemens Desigo DXR2 · Exploitation: unlikely (under 1%)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

0.9%probability of exploitation in the next 30 days
58th percentile
050100

Higher than 58% of scored CVEs

Not scored yet. The CVE record carries no CVSS score.

DescriptionCVE.org

A vulnerability has been identified in Desigo DXR2 (All versions < V01.21.142.5-22), Desigo PXC3 (All versions < V01.21.142.4-18), Desigo PXC4 (All versions < V02.20.142.10-10884), Desigo PXC5 (All versions < V02.20.142.10-10884). The web application fails to enforce an upper bound to the cost factor of the PBKDF2 derived key during the creation or update of an account. An attacker with the user profile access privilege could cause a denial of service (DoS) condition through CPU consumption by setting a PBKDF2 derived key with a remarkably high cost effort and then attempting a login to the so-modified account.

Affected products4

From the CVE record. A product or version that is not listed is unknown, not unaffected.

  • Siemens · Desigo DXR2All versions < V01.21.142.5-22
  • Siemens · Desigo PXC3All versions < V01.21.142.4-18
  • Siemens · Desigo PXC4All versions < V02.20.142.10-10884
  • Siemens · Desigo PXC5All versions < V02.20.142.10-10884

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas
Exploitation
Unlikely (under 1%). EPSS under 1%, or no score yet.
CISA KEV
Not listed
Public check
No public nuclei template
Vendor
Siemens
Published
May 2022

CoverageNo articles yet

No CyberSIXT article names CVE-2022-24040 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.

References

Updated AboutDevelopersSign in